Steven Allen to Treatment Outcome
This is a "connection" page, showing publications Steven Allen has written about Treatment Outcome.
Connection Strength
0.137
-
Allen SR, Slaughter MS, Ahmed MM, Bartoli CR, Dhingra R, Egnaczyk GF, Gulati SK, Kiernan MS, Mahr C, Meyer DM, Motomura T, Ono M, Ravichandran A, Shafii A, Smith J, Soleimani B, Toyoda Y, Yarboro LT, Dowling RD. COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant. 2023 01; 42(1):33-39.
Score: 0.100
-
Lewcun JA, Khatun R, Allen S, Hazelton JP, Cooper A. Patient Outcomes in Mesenteric Venous Thrombosis Treated With Empiric Antibiotics. Am Surg. 2021 Apr; 87(4):658-663.
Score: 0.022
-
Stone RM, Mazzola E, Neuberg D, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, Erba HP, Damon L, Jang JH, Tallman MS, Warzocha K, Masszi T, Sekeres MA, Egyed M, Horst HA, Selleslag D, Solomon SR, Venugopal P, Lundberg AS, Powell B. Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia. J Clin Oncol. 2015 Apr 10; 33(11):1252-7.
Score: 0.015